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1. Allergic & Irritant Dermatitis
Boris Lushniak (NIOSH)
Alan Moshell (National Institute of Arthritis
and Musculoskeletal and Skin Diseases)
Carol Burnett (NIOSH)
David Bernstein (University of Cincinnati)
Frances Storrs (Oregon Health Sciences
University)
G. Frank Gerberick (Proctor & Gamble
Company)
Mark Boeniger (NIOSH)
Michael Luster (NIOSH)
Raymond Biagini (NIOSH)
Richard Fenske (University of Washington)
Stephen Berardinelli (NIOSH)
Susan Wilburn (American Nurses
Association)
Albert Munson (NIOSH)
James Johnson (Lawrence Livermore
National Laboratory)
2. Asthma & Chronic Obstructive
Pulmonary Disease
Kathleen Kreiss (NIOSH)
Robert Castellan (NIOSH)
David Wegman (University of Massachusetts,
Lowell)
Edward L. Petsonk (NIOSH)
Hillel Koren (Environmental Protection
Agency)
Jeffery Fedan (NIOSH)
John Balmes (University of California San
Francisco)
Paul Henneberger (NIOSH)
Phillip Morey (AQS Services)
Susan Kennedy (University of British
Columbia)
Suzanne Hurd (National Heart, Lung and
Blood Institute)
Gail Wienmann (National Heart, Lung and
Blood Institute)
3. Fertility & Pregnancy Abnormalities
Teresa Schnorr (NIOSH)
Barbara Grajewski (NIOSH)
Coleen Boyle (National Center for Environ-
mental Health)
Eisuke Murono (NIOSH)
Kenneth Bridbord (Fogarty International
Center)
Melissa McDiarmid (University of Maryland)
Michele Marcus (Emory Universisty)
Ronald Gray (Johns Hopkins University)
Steven Schrader (NIOSH)
4.  Hearing Loss
John Franks (NIOSH)
Alton Burks (NIOSH)
Anthony Miltich (Digital Hearing Systems)
Carol Merry (NIOSH)
Daniel Johnson (EG&G)
Douglas Ohlin (Army Center for Health
Promotion and Preventative Medicine)
Howard Hoffman (National Institute on
Deafness and Communicative Disorders)
John Casali (Virginia Polytechnic Institute and
State University)
Patricia Brogan (Ford Motor Company)
Randy Tubbs (NIOSH)
5. Infectious Diseases
Robert Mullan (NIOSH)
William Denton (Denton International)
Craig Shapiro (National Center for Infectious
Diseases)
Adelisa Panlilio (National Center for
Infectious Diseases)
Jack Parker (NIOSH)
Joel Breman (Fogarty International Center)
Jordan Barab (American Federation of State,
County and Municiple Employees)
June Lunney (National Institute for Nursing
Research)
Kent A. Sepkowitz (Memorial Sloan-Kettering
Cancer Center)
Naresh Chawla (Food and Drug
Administration)
Teresa Seitz (NIOSH)
Yvette Davis (National Center for HIV,
Sexually Transmitted Disease, and TB
Prevention)
Yvonne Boudreau (NIOSH)
6. Musculoskeletal Disorders
Larry Fine (NIOSH)
Barbara Silverstein (State of Washington
Department of Labor and Industries)
Brian Peacock (General Motors Corporation)
Bruce Bernard (NIOSH)
Cherie Fairfield Estill (NIOSH)
Hongwei Hsiao (NIOSH)
James Panagis (National Institute of Arthritis
and Musculoskeletal and Skin Diseases)
LaMont Byrd ( International Brotherhood of
Teamsters)
Laura Welch (George Washington University)
Priscilla Shoemaker (American Health Care
Association)
Sean Gallagher (NIOSH)
Sue Schurman (George Meany Center for
Labor Studies)
Thomas Slavin (Navistar International
Transportation Corporation)
Thomas Leamon (Liberty Mutual Insurance
Company)
Vernon Putz Anderson (NIOSH)
7.  Traumatic Injuries
Nancy Stout (NIOSH)
William Borwegen (Service Employees
International Union)
Bradley Rein (Department of Agriculture)
George Conway (NIOSH)
Gordon Reeve (Ford Motor Company)
Gordon Smith (Johns Hopkins University)
Herbert Linn (NIOSH)
Jane Roemer (National Safety Council)
Karl Snyder (NIOSH)
Lisa Steiner (NIOSH)
Lynn Jenkins (NIOSH)
Nancy McWilliams (American Society of
Safety Engineers)
Rolf Eppinger (National Highway Transporta-
tion Safety Administration)
Stephen Luchter (National Highway
Transportation Safety Administration)
Tim Pizatella (NIOSH)
8. Indoor Environment
Mark Mendell (NIOSH)
William Fisk (Lawrence Berkeley Laboratory)
William Cain (University of California San
Diego)
Cynthia Hines (NIOSH)
Darryl Alexander (American Federation of
Teachers)
David Spannbauer (General Services
Administration)
Donald Milton (Harvard University)
Hal Levin (Hal Levin and Associates)
John Girman (Environmental Protection
Agency)
Kathleen Kreiss (NIOSH)
Marilyn Fingerhut (NIOSH)
Kenneth Wallingford (NIOSH)
Paul Jensen (NIOSH)
9. Mixed Exposures
Frank Hearl (NIOSH)
Alan Lunsford (NIOSH)
Robert Herrick(Harvard University)
Carlos Marentes (Rural Coalition)
Daniel Lewis (NIOSH)
Douglas Trout (NIOSH)
Gregory Burr (NIOSH)
Henry Gardner (Army Center for Environ-
mental Health Research)
Hugh Hansen (Agency for Toxic Substance
and Disease Registry)
John Bucher (National Institute of Environ-
mental Health Sciences)
Manuel Gomez (American Industrial Hygiene
Association)
Vera Kommineni (NIOSH)
10. Emerging Technologies
Theodore Schoenborn (NIOSH)
David Conover (NIOSH)
Elaine Cullen (NIOSH)
Jack Finklea (National Center for Injury
Control and Prevention)
Jeffery Welsch (NIOSH)
Kennith Brock (Safety Management
Consultant)
Max Keifer (NIOSH)
Nicholas Ashford (Massachusetts Institute of
Technology)
Raymond Lovett (West Virginia University)
Richard Hartle (NIOSH)
Tai Chan (General Motors Corporation)
11. Control Technology & Personal
 Protective Equipment
Fredrick Kissell (NIOSH)
William Kojola (Laborers’ Health and Safety
Fund)
William Heitbrink (NIOSH)
Dale Avery (NIOSH)
Daniel Shipp (Industrial Safety Equipment
Association)
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NIOSH Vision
Delivering on the Nation’s promise:
safety and health at work for all
people...through research and
prevention.
NORA Vision
No single organization has the
resources necessary to conduct
occupational safety and health
research to adequately serve the
needs of workers in the United
States.  These constraints mandate
that the entire occupational safety
and health community engage in
collaboration and coordination of
its resources.  The National
Institute for Occupational Safety
and Health (NIOSH) and its public
and private partners developed the
National Occupational Research
Agenda (NORA) to provide a
framework to guide occupational
safety and health research into the
next decade—for NIOSH and the
entire occupational safety and
health community.
Message from NIOSH
The creation of the National Occupational Research Agenda (NORA) over a
year ago was truly a cooperative effort.  The National Institute for
Occupational Safety and Health  (NIOSH) relied heavily on the expertise and
input of our partners in the public and private sector to create an agenda to
guide occupational safety and health research into the next decade.  Over
the last year, we have had many successes and learned much as we
undertook the monumental task of implementing the Research Agenda.
One of the most exciting aspects of NORA implementation is the enthusiasm
and support we continue to receive from our partners.  This is probably best
exemplified in the makeup of the NORA teams.  Teams include members of
academia, professional associations, NIOSH, other Government agencies,
industry, and labor.  We would personally like to thank all NORA team
members.  Their commitment and diligence are helping to drive the
implementation process.
The Liaison Committee has also played a critical role in guiding the NORA
implementation efforts.  The committee has assisted with continued
outreach, tracking and measuring our progress, and facilitating research in a
number of areas.
This document provides an overview of NORA and our progress since the
Agenda was unveiled one year ago.  We appreciate and look forward to the
continued involvement and support of the occupational safety and health
community in this important effort.
Linda Rosenstock, M.D., M.P.H.
Director
William Halperin, M.D., Dr.P.H.
Deputy Director
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Liaison Committee Perspective
In the last year, the NORA Liaison Committee has worked with NIOSH to begin
the  transformation of NORA from an ambitious concept to a practical reality.
The Liaison Committee consists of members from academia, labor, industry,
and professional organizations.  Our role is to provide outreach and
commentary on the development, progress, and direction of NORA.
Establishment of 20 NORA teams which include NIOSH staff and partners
from academia, labor, industry, professional organizations, and other
Government agencies has been the major focus of this past year.  The teams
will provide visionary leadership for their NORA area of occupational safety
and health research. Their enthusiasm and activity in this first year have been
remarkable.
The growth of the NORA teams is only one product of NORA.  Although it is
still early, it is already apparent that there has been an increase in investment
in NORA research areas.  This is due, in part, to changes in the research
focus within NIOSH.  However, there is also evidence that NORA has
facilitated cooperation among Federal agencies and with industry and labor
that will provide new resources for research in these high-priority areas.
No one holds a strict blueprint for how NORA will proceed.  However, NORA
has harnessed the enthusiasm of many, including the priority area team
members and the Liaison Committee.  NORA is readily catalyzing interest and
research activity, which is the interim goal of NORA.  This will lead to the
ultimate goal of prevention of occupational injury and disease.  The Liaison
Committee is pleased to work with NIOSH and the occupational safety and
health community in the implementation of NORA.  Best wishes to all partners
for continued success.
Bonnie Rogers, R.N., Ph.D.
Chairperson, NORA Liaison Committee
American Association of Occupational Health Nurses
NORA Implementation
The success of NORA will be commensurate with the degree to which the
entire occupational safety and health community engages in collaboration
and coordination.  NIOSH has facilitated the formation of partnerships that
will assist in the development, pursuit, review, and dissemination of research
under each NORA topic.  NIOSH will build upon and extend these partnerships
and work to improve coordination throughout the occupational safety and
health community, with the expectation that these activities will ultimately
lead to improved worker protection and well-being.
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Liaison Committee
Robin Baker
American Public Health Association
Jordan Barab
American Federation of State, County and
Municipal Employees
Thomas F. Bresnahan
American Society of Safety Engineers
William B. Bunn
Navistar International Transportation
Corporation
Tai Chan
General Motors Corporation
Gwendolyn Puryear Keita
American Psychological Association
Heidi Klein
National Association of County and City
Health Officials
Sandra Lange
National Institute of Environmental Health
Sciences
Thomas Leamon
Liberty Mutual Insurance Company
Wayne Lednar
Eastman Kodak Company
Pamela Tau Lee
Tai Community Development Center and
Labor Occupational Health Program
Joseph Main
United Mine Workers of America
Zackary Mansdorf
American Industrial Hygiene Association
Joseph Mathey
Corning Incorporated
Franklin Mirer
United Auto Workers
Clifford Mitchell
American College of Occupational and
Environmental Medicine
Association of Occupational and
Environmental Clinics
Carolyn Phillips
Chemical Manufacturers Association
Knut Ringen
Center to Protect Workers’ Rights
Jane Roemer
National Safety Council
Margaret Seminario
AFL-CIO
Frank White
Organization Resources Counselors,
Incorporated
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An Agenda for the 21st Century
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  NORA Priority Research Areas
 CATEGORY PRIORITY RESEARCH AREAS
 Disease and Injury Allergic and Irritant Dermatitis
Asthma and Chronic Obstructive Pulmonary Disease
Fertility and Pregnancy Abnormalities
Hearing Loss
Infectious Diseases
Low Back Disorders
Musculoskeletal Disorders of the Upper Extremities
Traumatic Injuries
 Work Environment and Emerging Technologies
 Workforce Indoor Environment
Mixed Exposures
Organization of Work
Special Populations at Risk
 Research Tools Cancer Research Methods
 and Approaches Control Technology and Personal Protective Equipment
Exposure Assessment Methods
Health Services Research
Intervention Effectiveness Research
Risk Assessment Methods
Social and Economic Consequences of Workplace
    Illness and Injury
Surveillance Research Methods
The National Institute for Occupational Safety and Health (NIOSH) and its
partners in the public and private sectors developed the National
Occupational Research Agenda (NORA) to provide a framework to guide
occupational safety and health research into the next decade—not only for
NIOSH, but also for the entire occupational safety and health community.
Approximately 500 organizations and individuals outside of NIOSH provided
input into the development of the Agenda.  This first-ever attempt to guide
and coordinate research nationally responds to a broadly perceived need to
systematically address those topics that are most pressing and most likely to
benefit workers and the Nation.  Fiscal constraints on occupational safety and
health research are increasing, making even more compelling the need for a
coordinated and focused research agenda.
The Agenda identifies 21 research priorities (see table below).  These
priorities reflect a remarkable degree of concurrence among a large number
of stakeholders.  The NORA priority research areas are grouped into three
categories:  Disease and Injury, Work Environment and Workforce, and
Research Tools and Approaches.  The priorities are not ranked and reflect an
attempt to consider both current and emerging needs.
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As we move into the next century, NORA is needed for a myriad of reasons.
Two, however, stand out in importance.  First, the current toll of occupational
injury and illness to American workers in particular and society in general is
unacceptable.  Each day in the United States, an average of 137 individuals
die from work-related diseases, and an additional 16 die from injuries on the
job.  Every 5 seconds a worker is injured; every 10 seconds a worker is
temporarily or permanently disabled.  Each year, about 70 youths under 18
years of age die from injuries at work and 64,000 require treatment in a
hospital emergency room.  In 1995, occupational injuries alone cost $119
billion in lost wages and productivity, administrative expenses, health care,
and other costs.  This high toll of work injuries and illnesses is not
irreversible.  In fact, significant progress has been made in improving worker
protection since the U.S. Congress passed the Occupational Safety and
Health Act in 1970.  This progress has been largely based on actions—
sometimes voluntary, sometimes regulatory—directed by the science and
knowledge generated from occupational safety and health research.
Second, the U.S. workplace is rapidly changing.  The distribution of jobs in
our economy continues to shift from manufacturing to services.  Longer
hours, compressed workweeks, shiftwork, reduced job security, and part-time
and temporary work are realities of the modern workplace.  New chemicals,
materials, processes, and equipment are developed and marketed at an ever
accelerating pace.  The workforce is also changing.  As the U.S. workforce
grows to an estimated 147 million by the year 2005, it will become older and
more racially diverse.  By the year 2005, minorities will represent 28% of the
workforce and women will constitute approximately 48%.  These changes will
present new challenges for protecting worker safety and health.  NORA will
help us meet these challenges in the next decade and beyond.
Each day, an average
of 137 individuals die
from work-related
diseases, and an
additional 16 die from
injuries on the job.
Every 5 seconds a
worker is injured;
every 10 seconds a
worker is temporarily
or permanently
disabled.
Each year, about 70
youths under 18 years
of age die from
injuries at work and
64,000 require
treatment in a hospital
emergency room.
In 1995, occupational
injuries alone cost
$119 billion in lost
wages and
productivity,
administrative
expenses, health care,
and other costs.
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NORA Implementation:
Update of Activities
Providing Guidance and Direction: the NORA Liaison Committee
During the creation of NORA, there were three liaison committees (corporate, worker, and outreach) that provided
outreach to individuals and organizations outside of NIOSH and assisted in the formation of the Agenda.  In part because
of the success of effective coordination in the development of the Agenda, it was decided that only a single liaison
committee was needed in the implementation phase.  The NORA Liaison Committee, chaired by Dr. Bonnie Rodgers,
President, AAOHN, consists of 22 members who represent industry, labor, academia, professional organizations, and
Government.  The Liaison Committee has the broad and important task of assisting in the successful implementation of
NORA by actively providing comments to NIOSH and its partners on the progress of NORA, providing outreach to
interested stakeholders, encouraging participation in research teams, and facilitating appropriate avenues for initiating
the proposed research.
Partnership Teams
Creating Partnership Teams - Partnership teams are a key part of implementing the Agenda.  As envisioned last year
when the Agenda was announced, these teams were to be formed to assist in the “development, pursuit, review, and
dissemination of research under each NORA topic.”  The teams were to include a broad representation of the occupa-
tional safety and health community.
Over the past year, this vision of NORA became a reality with the formation of 20 research priority partnership teams
(two priority areas—musculoskeletal disorders of the upper extremities and low back disorders—are being addressed
by one team).  This overall effort has brought together 121 NIOSH researchers and 146 external partners.
The teams generally consist of a team leader and a combination of NIOSH researchers and external partners.  Member-
ship on these teams includes, among others, faculty from public and private colleges and universities, representatives
of professional organizations, major manufacturing industries, leaders in the insurance industry, health and safety
professionals from organized labor, and representatives from other Government agencies.
Team membership
Affiliations Number
Academia 45
Labor 16
Industry 21
Professional organizations 7
NIOSH 121
CDC (non-NIOSH) 8
Other Government agencies 40
Other 9
Total 267
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ON The variety of activities pursued by the NORA teams reflects the diversity ofthe NORA research priority areas.Disseminating Information - During the first year, a number of the teamsreached out into the occupational safety and health community to raiseawareness about their priority areas.  For example:
• The Asthma and Chronic Obstructive Pulmonary Disease Team
organized a panel of Federal partners for the March 1997 National
Latex Allergy Conference and held a  labor/management-sponsored
workshop on the respiratory effects of metal working fluids in the
automotive industry.
• The Allergic and Irritant Dermatitis Team conducted presentations
at meetings of the American Contact Dermatitis Society, International
Dermatoepidemiology Association, the American Academy of Dermatol-
ogy, and the Universities of Pennsylvania and Washington.
• The Intervention Effectiveness Research Team prepared a manu-
script that summarizes research needs for presentation at the Ameri-
can Public Health Association Conference later this year.
• The Traumatic Injuries Team is playing a leading role in planning the
first National Injury Research Symposium to be held in October, 1997.
• The Control Technology and Personal Protective Equipment
Team has been actively involved in planning a first-of-its-kind compre-
hensive control technology workshop in March 1998, where a more
focused and ambitious action plan in this area will be developed.
Defining Issues and Research Areas - For a number of teams, the past
few months have been used to better conceptualize and define the issues
involved or to conduct needs assessments in their topic areas.  For example:
• The Fertility and Pregnancy Abnormalities Team is conducting a
needs assessment in the areas of surveillance, field studies, and
toxicology.
• The Indoor Environment Team has produced a conceptual model
based on categories of health effects that will help organize the diverse
elements within this broad topic.
• The Mixed Exposures Team has begun to define the scope of this
very complex topic and is examining mechanisms to identify and
describe the most pressing research needs in the area.
• The Special Populations at Risk Team has divided into six subareas
(older workers, child labor, disabled workers, women, minorities, and
environmental justice) to identify operational definitions for the specific
populations, specific problems, research needs, and possible outcomes
and benefits of research.
Research Team Activities
6 National Occupational Research Agenda
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• The Organization of Work Team has focused on defining organization of
work and identifying critical cross-cutting issues of work organization and
other NORA priority areas.
• The Infectious Diseases Team has divided into four subgroups covering
HIV, HBV and HCV, TB, and infection control and education and is focusing on
research needs pertaining to these areas.
• The Emerging Technologies Team is working to define the boundaries of
the health problems associated with emerging technologies and to develop
an inventory of current risk analysis activities for use in a workshop that
examines the effects of emerging technologies on workers.
All of the teams report progress in working together toward the common goal
of focusing the efforts of the entire occupational safety and health community
on the 21 NORA priorities.  NIOSH remains committed to maintaining a
leadership role in facilitating the activities of the NORA partnership teams.
Cementing and Expanding Partnerships -  NORA brought together 500
organizations and individuals for one purpose: to create a Research Agenda.
To fully implement the Agenda, multiple partnerships must be formed or
continued.  In addition to the partnership activities embodied in the NORA
teams, NIOSH and its Federal partners have continued to build upon their
commitment to NORA.
Federal Partnerships
One early success is a joint program announced between the National
Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and
NIOSH to support two extramural research programs.  The first initiative
invites studies on repetitive motion disorders; the second, on low back pain.
Federal partners also remain involved in the implementation process through
membership on the partnership teams and tracking of NORA-related research
activities.
A major activity for the Federal partners this year was the development of
Federal baseline data to assess the overall Federal investment in NORA
research priority areas during FY96.  This survey was sent to all Federal
partners (see listing).
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Participating Federal Agencies
FEDERAL AGENCY OFFICE/INSTITUTE/DIVISION
Consumer Product Safety Commission Directorate for Epidemiology and Health Sciences
Department of Agriculture Cooperative State Research, Education and Extension Service
Department of Defense Naval Medical Research and Development Command
Department of Energy Office of the Environment, Safety and Health
Department of Health and Human Services Agency for Health Care Policy and Research
Agency for Toxic Substances and Disease Registry
Centers for Disease Control and Prevention
• Epidemiology Program Office
• International Health Program Office
• National Center for Chronic Disease Prevention and Health Promotion
• National Center for Environmental Health
• National Center for Health Statistics
• National Center for HIV, Sexually Transmitted Disease, and TB Prevention
• National Center for Infectious Diseases
• National Center for Injury Prevention and Control
• National Immunization Program
• Office of Minority Health
• Office of Women’s Health
• Public Health Practice Program Office
Food and Drug Administration
Health Resources and Services Administration
Intergovernmental Affairs
National Institutes of Health
• Fogarty International Center
• National Cancer Institute
• National Heart, Lung, and Blood Institute
• National Institute of Allergy and Infectious Diseases
• National Institute of Arthritis and Musculoskeletal and Skin Diseases
• National Institute of Environmental Health Sciences
• National Institute of Mental Health
• National Institute of Neurological Disorders and Stroke
• National Institute of Nursing Research
Substance Abuse and Mental Health Services Administration
Department of Justice National Institute of Justice
Department of Labor Bureau of Labor Statistics
Mine Safety and Health Administration
Occupational Safety and Health Administration
Wage and Hour Division
Department of Transportation Federal Aviation Administration
National Highway Traffic Safety Administration
Department of Treasury Internal Revenue Service
Environmental Protection Agency National Exposure Research Laboratory
Office of Prevention, Pesticides, and Toxic Substances
Executive Office of the President Office of Science and Technology Policy
Office of Policy Development
• Domestic Policy Council
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Measuring the Success of NORA
The success of NORA will be measured over the long run by its role in
effectively directing occupational safety and health research to prevent
occupational illness and injury.  As the NORA priorities become disseminated
throughout the occupational safety and health community, this Nation should
see improvements in worker safety and health.  There are, however, many
steps in a continuum of activities between the initial recognition that research
is needed and the successful implementation of interventions that lead to
prevention.  To measure the success of NORA and to provide meaningful
information by which to redirect or refocus NORA activities, it is necessary to
identify and track progress on the continuum of activities leading to preven-
tion.  Measures that we propose to track are:
• NIOSH’s research investment
• Other Federal agencies’ research investment
• Funding of grant applications in NORA priority areas
• Research literature
• Prevention and intervention activities arising out of NORA
Tracking NIOSH’s Research Investment
The goals of NORA include the allocation of research resources into high-
priority NORA research areas.  The first evidence that NORA will be success-
ful is the redirection of resources in NIOSH’s research programs, which has
shown a significant increase in spending in NORA priority areas in just one
year, using 1996 as a baseline (the year in which the Agenda was an-
nounced).  For the data reported below, a research project was considered
as NORA-related if at least 80% of project resources were committed to one
of the 21 priority areas. In other words, some projects addressing NORA
priority areas were not counted using this relatively strict criterion.  Moreover,
an independent team of NIOSH scientists determined whether projects met
NORA criteria, excluding, for example, traditional cancer research and routine
surveillance activities which did not have as a focus the development and
testing of new research methods.
* Allocations reflect largely intramural research; extramural cooperative agreements and contracts are included, but
extramural grants (which are still in the process of being funded in FY97) and training and research center activities
are not included in either year .
NIOSH Investment in NORA*
(in millions)
20
15
10
5
0
FY96 FY97
(estimated)
$18.3
$8.7
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Tracking Other Federal Agencies’ Research Investment
NIOSH and its Federal partners have designed and implemented a survey of NORA-related research investments by
Federal agencies other than NIOSH.  NORA-related research by these Federal partners for 1996 is estimated at almost
$15 million (out of a reported total budget of about $8 billion).
The overall Federal investment, about $24 million in 1996 (NIOSH and Federal partners), is the baseline against which
future NORA investment will be compared.
Tracking Funding of Grant Applications
in NORA Priority Areas
We expect that an early indication of increased interest in NORA area research will be increased applications for re-
search funding.  Beginning in 1997, research applications to NIOSH and select Federal partners will be tracked by
NORA area.  In addition, cosponsorship by NIOSH and other Federal agencies of research in NORA priority areas can be
followed, such as the previously noted joint program announcement by NIAMS and NIOSH in the two musculoskeletal
priority areas.
Tracking the Research Literature
Searching and reviewing the literature is an inherent part of conducting research.  Bibliometrics is the quantitative
assessment of the incidence, trends, and impact of published literature.  It adds another dimension to the role of
literature review in research.  As NORA leads to greater research activity, there will be an accompanying increase in the
number of publications in the priority areas.  This year, NIOSH explored a number of approaches to the quantitative
tracking of publications in the scientific literature.  These will be pursued in specific priority areas in the future.
Tracking, Prevention, and Intervention
Activities Arising Out of NORA
The ultimate success of research is in its translation into effective preventive action.  We propose to measure the
success of NORA by tracking awareness (e.g. information dissemination) and preventive actions that arise out of NORA
activity.  This may include actions by employers and workers at the work site, industry-wide adoption of control or
abatement measures,  intervention research, or publication and dissemination of information.  Measuring these actions
is a challenge; however, NIOSH and its partners are committed to defining a systematic approach to assess such
impacts for at least some of the NORA priority areas in some settings.
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Examples of NORA Successes
National Occupational Injury Research
Symposium (NOIRS)
NOIRS grew out of a recognition that a national research symposium on
occupational traumatic injuries would not only facilitate exchange of current
research information, but would also catalyze growth of interest in research
regarding the prevention of traumatic occupational injuries.  NOIRS is planned
for October 15-17, 1997, in Morgantown, West Virginia.  Response to NOIRS
has been exhilarating; a large number of partners have joined with NIOSH to
sponsor NOIRS.  Several other NORA teams, e.g., the Risk Assessment
Methods Team and the Intervention Effectiveness Research Team, have
organized symposium panels on the interface between their team’s work and
that of the Traumatic Injuries Team.
Allergic and Irritant Dermatitis
On September 25-26, 1996, as a stepping stone for the NORA implementa-
tion phase, NIOSH sponsored the Workplace-Related Skin Diseases and
Exposure Assessment Workshop to identify key workplace-related research
issues and data gaps in three areas of occupational skin disease research:
laboratory-based biomedical research, exposure assessment, and epidemio-
logic and prevention-oriented issues.  Topics identified during the workshop
will be the subject of future teamwork, including efforts to fill identified
research gaps by facilitating research in critical areas.
Latex Allergy
During the creation of NORA, town hall meetings provided a forum for nurses
and other health care providers to deliver a strong message regarding the
epidemic of latex allergy among U.S. health care workers.  Latex allergy is
addressed in two NORA priority areas: Allergic and Irritant Dermatitis, and
Asthma and Chronic Obstructive Pulmonary Disease.  In addition, NIOSH
formed an internal latex allergy working group to develop recommendations
to prevent allergic reactions to latex in the workplace.  In FY97, NIOSH will
begin field, laboratory, and intervention studies of latex allergy.  At the 1997
National Latex Allergy Conference, NIOSH organized a panel of key stakehold-
ers, including the Occupational Safety and Health Administration (OSHA), Food
and Drug Administration (FDA), Health Industry Manufacturers Association
(HIMA), American Hospital Association (AHA), and American Nurses Associa-
tion (ANA) to identify future actions for preventing latex allergy.  NORA teams
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plan to stimulate the following research and prevention activities:  a NIOSH
cooperative agreement on exposure-response and threshold studies in the
health care industry, an assessment of  latex seroprevalence in the National
Health and Nutrition Examination Survey (NHANES) IV, publication of National
Latex Allergy Conference panel consensus recommendations, collaborative
public/private funding of needed research, and a consensus standard from
the American Society of Testing Methods (ASTM) to address the problem.
Summary
The first year of NORA has been encouraging because it has seen—
• The formation, commitment, and enthusiastic input of a broad-based NORA
Liaison Committee.
• The formation and successful efforts of 20 NORA teams with broad-based
membership.
• The participation of a large number of Federal agencies in NORA activities.
• The first survey of Federal occupational safety and health (including NORA)
research investment.
• The participation of a broad array of partners in a series of activities,
including conferences and symposia, in NORA priority areas.
• The evidence that a national Research Agenda was and continues to be
needed and that NORA research priority areas have been well chosen.
• The recognition that NORA is a model for public-private partnerships.
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(continued from front cover)
11. Control Technology & Personal
 Protective Equipment, cont.
David de Vries (American Society of Safety
Engineers)
Donald Campbell (NIOSH)
John Meagher (American Industrial Hygiene
Association)
Lawrence Reed (NIOSH)
Michael Flynn (University of North Carolina at
Chapel Hill)
Nancy Bollinger (NIOSH)
Richard Duffy (International Association of
Fire Fighters)
Sidney Soderholm (NIOSH)
Steven Mallinger (Occupational Safety and
Health Administration)
Steven Berardineli (NIOSH)
Christina Gomberg (NIOSH)
12. Organization of Work
Steven Sauter (NIOSH)
Robert Peters (NIOSH)
David LeGrande (Communication Workers of
America)
Gwendolyn Puryear Keita (American
Psychological Association)
Jeanne Stellman (Columbia University)
Joseph Hurrell (NIOSH)
Lawrence Murphy (NIOSH)
Lois Tetric (University of Houston)
Mary Lewis (NIOSH)
Michael Colligan (NIOSH)
Nancy Lessin (Massachusetts Coalition for
Occupational Safety and Health)
Naomi Swanson (NIOSH)
William Halperin (NIOSH)
Richard Lippin (ARCO Chemical Corporation)
13. Special Populations at Risk
Gwendolyn Cattledge (NIOSH)
Andrea K. Taylor (United Auto Workers)
Ann Fidler (NIOSH)
Anthony Yancey (NIOSH)
Robert Rinsky (NIOSH)
Charles Lee (United Church of Christ)
Dawn Castillo (NIOSH)
Frances Henderson (Alcorn State University)
Gayle DeBord (NIOSH)
Howard Frumkin (Emory University)
Joni Barnett (National Center for Farmworker
Health)
Letitia Davis (Massachusetts Department of
Health)
Lorrie Cameron (NIOSH)
Pam Tau Lee (Labor Occupational Health
Program)
Theodore Meinhardt (NIOSH)
14. Cancer Research Methods
Elizabeth Ward (NIOSH)
Ann Hubbs (NIOSH)
Carrie Redlich (Yale University)
Michael Sprinker (International Chemical
Workers Union Council)
Christine Sofge (Occupational Safety and
Health Administration)
David Dankovic (NIOSH)
James Bond (Chemical Industry Institute of
Toxicology)
Mary Ann Butler (NIOSH)
Myra Karstadt (Environmental Protection
Agency)
Ainsley Weston (NIOSH)
Nathaniel Rothman (National Cancer Institute)
Ronald Herbert (National Institute of Environ-
mental Health Sciences)
15. Surveillance Research Methods
John Sestito (NIOSH)
Alice Greife (Central Missouri State University)
Barbara Fotta (NIOSH)
William Weber (Bureau of Labor Statistics)
Robert Castellan (NIOSH)
Denise Koo (Epidemiology Program Office,
Centers for Disease Control)
Diane Wagener (National Center for Health
Statistics)
Earl Pollack (Center to Protect Workers’
Rights)
Eric Frumin (Union of Needletrades, Industrial
and Textile Trade Employees)
Henry Anderson (Wisconsin Department of
Health and Social Services)
Jane McCammon ( Colorado Department of
Public Health and Environment)
John Myers (NIOSH)
Leroy Mickelson (NIOSH)
Richard Ehrenberg (NIOSH)
Steven Newell (Occupational Safety and Health
Administration)
Wayne Ledner (Eastman Kodak Company)
16. Exposure Assessment Methods
Mary Lynn Woebkenberg (NIOSH)
Elizabeth Reh (NIOSH)
Bonnie Rogers (American Association of
Occupational Health Nurses)
David Pegram (Department of Energy)
R. DeLon Hull (NIOSH)
Eric Sampson (National Center for Environmen-
tal Health)
Gary Spies (Monsanto Company)
James Weeks (George Washinton University)
Kenneth Williams (NIOSH)
Lawrence Elliott (NIOSH)
Martin Abell (NIOSH)
Michael Keane (NIOSH)
Paul Knechtges (Naval Medical Research and
Development Command)
17. Risk Assessment Methods
Leslie Stayner (NIOSH)
William Perry (Occupational Safety and Health
Administration)
William Fayerweather (Owens Corning
Corporation)
William Farland (Environmental Protection
Agency)
Bryan Hardin (NIOSH)
Christopher Portier (National Institute of
Environmental Health Sciences)
Dale Hattis (Clark University)
Frank Mirer (United Auto Workers)
Gerald van Belle (University of Washington)
Mark Torrasson (NIOSH)
Michael Attfield (NIOSH)
James T. Wassell (NIOSH)
18. Intervention Effectiveness Research
Linda Goldenhar (NIOSH)
Ann Brockhaus (Organization Resource
Counselors Inc.)
Anthony LaMontangne (New England
Research Institutes)
Carolyn Needleman (Bryn Mawr College)
Daniel Murphy (St. Paul Fire and Marine
Insurance Company)
Janet Johnston (NIOSH)
Lawrence Chapman (University of  Wisconsin)
Naomi Swanson (NIOSH)
Paul Landsbergis (Cornell University)
Paul Schulte (NIOSH)
Raymond Sinclair (NIOSH)
Robin Baker (Univesity of California Berkeley)
Sarah Glavin (General Accounting Office)
Scott Schneider (Center to Protect Workers’
Rights)
Scott Earnest (NIOSH)
19. Health Services Research
Scott Deitchman (NIOSH)
William Bunn (Navistar International Transpor-
tation Corportation)
David Michaels (City Univerisity of New York)
Gregory Wagner (NIOSH)
Janice Klink (NIOSH)
Janie Gordon (University of Maryland)
Jay Himmelstein (University of Massachusetts)
Joan Buchanan (Harvard University)
Karen Worthington (NIOSH)
Kathleen Rest (University of Massachusetts)
Linda Rudolph (California Department of
Industrial Relations)
Mary Cunnings (Agency for Health Care Policy
Research)
Rosemary Sokas (Occupational Safety and
Health Administration)
Thomas Hodous (NIOSH)
20. Social & Economic Consequences of
Workplace Illness & Injury
Leslie Boden (Boston University)
Ross A. Fabricant (NIOSH)
Allan Hunt (Upjohn Institute for Employment
Research)
William Halperin (NIOSH)
Brian Day (NIOSH)
Chuck Levenstein (University of Massachu-
setts, Lowell)
Cynthia Madden (University of Washington)
Emily Spieler (West Virgina University)
Harry Shannon (Institute for Work and Health)
Lou Fintor (NIOSH)
Paul Keane (NIOSH)
Sharon Morris (University of Washington)
Theodor Miller (Pire Associates)
Thomas Camm (NIOSH)
Elyce Biddle (NIOSH)
For additional information, contact NIOSH at:
National Institute for Occupational Safety and Health
Publications Dissemination
4676 Columbia Parkway
Cincinnati, OH  45226-1998
1-800-35-NIOSH
(1-800-356-4674)
Fax: 513-533-8573
or visit the NIOSH homepage on the World Wide Web at
http://www.cdc.gov/niosh/homepage.html
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